Clinical Trials on Malignant Metastatic Melanoma
Total 15356 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGenetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV MelanomaMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Metastatic Malignant Solid Neoplasm | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Solid Neoplasm | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma... and other conditionsUnited States
-
European Organisation for Research and Treatment...TerminatedMetastatic Cancer | Intraocular MelanomaSwitzerland, Italy, United Kingdom, Poland
-
Craig L Slingluff, JrUniversity of VirginiaCompletedMelanoma | Metastatic Melanoma | Mucosal MelanomaUnited States
-
Ludwig Institute for Cancer ResearchUniversity of Chicago; University of Pittsburgh; Life Science PharmaceuticalsCompletedPhase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic MelanomaMetastatic Melanoma | Cutaneous MelanomaUnited States
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Unresectable MelanomaUnited States, France
-
Cancer Trials IrelandCompletedMetastatic Melanoma | Advanced MelanomaIreland
-
Dana-Farber Cancer InstitutePartner Therapeutics (PTx)WithdrawnMetastatic Melanoma | Unresectable Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Pfizer; Beth Israel Deaconess Medical CenterCompletedMucosal Lentiginous Melanoma | Acral Lentiginous Malignant MelanomaUnited States
-
University of Colorado, DenverNational Comprehensive Cancer Network; Taiho Oncology, Inc.RecruitingMalignant MelanomaUnited States
-
Quanli GaoNot yet recruiting
-
Inge Marie SvaneTechnical University of DenmarkRecruiting
-
A.J.M. van den EertweghIdera Pharmaceuticals, Inc.Recruiting
-
Uppsala UniversityRecruiting
-
Universitair Ziekenhuis BrusselRecruitingMalignant MelanomaBelgium
-
Immunocore LtdAstraZenecaCompletedMalignant MelanomaUnited States
-
St. Jude Children's Research HospitalSchering-PloughActive, not recruitingMalignant MelanomaUnited States
-
Lokon Pharma ABPrecision Oncology LLCCompletedMalignant MelanomaSweden, United States
-
Immodulon Therapeutics LtdTerminatedMalignant MelanomaUnited Kingdom
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteCompletedMalignant MelanomaUnited States
-
Linkoeping UniversityKarolinska Institutet; Region Östergötland; Region Stockholm; Kronoberg County... and other collaboratorsCompleted
-
Ludwig Institute for Cancer ResearchTerminated
-
Ludwig Institute for Cancer ResearchCancer Research Institute (CRI)CompletedMalignant MelanomaUnited States
-
Ludwig Institute for Cancer ResearchTerminated
-
4SC AGCompletedMalignant MelanomaGermany, Italy
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia, Brazil, Spain, South Africa, Ukraine, Bosnia and Herzegovina
-
Ultimovacs ASAOslo University HospitalActive, not recruiting
-
University of Kansas Medical CenterCompletedMalignant MelanomaUnited States
-
University of BaselUniversity Hospital, Basel, SwitzerlandCompletedMalignant Melanoma
-
CelgenePrologue Research InternationalCompleted
-
Eli Lilly and CompanyCompletedMalignant MelanomaUnited States
-
Milton S. Hershey Medical CenterCompletedMalignant MelanomaUnited States
-
Skin Analytics LimitedCompleted
-
University of ArizonaTerminatedMalignant MelanomaUnited States
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.UnknownMalignant MelanomaChina
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
Hoffmann-La RocheCompleted
-
University of California, DavisCompletedMelanoma | Malignant MelanomaUnited States
-
AstraZenecaCompletedMelanoma | Malignant MelanomaUnited Kingdom, Netherlands
-
University Hospital TuebingenGerman Research FoundationCompleted
-
AstraZenecaCompleted
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Bristol-Myers SquibbCompletedMalignant MelanomaUnited States
-
SentoClone ABUnknownMalignant MelanomaSweden
-
Royal Marsden NHS Foundation TrustUnknown
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruiting